Medochemie

Medochemie Ltd was established in 1976 by Dr. Andreas Pittas and has since evolved into the largest pharmaceutical company in Cyprus. Today, Medochemie operates fifteen state-of-the-art manufacturing facilities: nine in Cyprus, one in the Netherlands, and five in Vietnam, all EU GMP certified. Exporting to more than 122 countries, with offices in 19 and an extended network of trusted agents and partners, Medochemie is one of the top 200 generic drug manufacturers globally. The company’s portfolio includes 500 product combinations under 5,145 marketing authorisations, spanning over 10 therapeutic categories, including prescription and over-the-counter medicines.

With a team of 2,000 skilled professionals, 45% of whom are scientists, Medochemie operates with a commitment to excellence, innovation, and strict adherence to international quality standards. Medochemie is proud to contribute significantly to Cyprus' economy, accounting for 28.9% of the country’s industrial exports.